Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Neurotoxicology and Teratology
|
March 1, 1989
Effect of perinatal monosodium glutamate administration on visual evoked potentials of juvenile and adult rats
G C Rigdon, W K Boyes, R S Dyer
Journal of Medicinal Chemistry
|
August 5, 1994
Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents
M H Norman, G C Rigdon, F Navas, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents
M H Norman, G C Rigdon, W R Hall, et al.
Journal of Medicinal Chemistry
|
November 22, 1996
Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents
M H Norman, F Navas, J B Thompson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1983
Dissimilar responses of cortical neurons to chronic trazodone or desipramine treatment
S L Peterson, T C Napier, G C Rigdon, et al.
Life Sciences
|
January 1, 1995
Is clozapine selective for the dopamine D4 receptor?
M J Durcan, G C Rigdon, M H Norman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1993
A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86
K J Chang, G C Rigdon, J L Howard, et al.
Electroencephalography and Clinical Neurophysiology
|
May 1, 1986
Generation of cortical event-related slow potentials in the rat involves nucleus basalis cholinergic innervation
J H Pirch, M J Corbus, G C Rigdon, et al.
Molecular Pharmacology
|
December 20, 2007
N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator
A D Wickenden, J L Krajewski, B London, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 1, 1996
1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects
G C Rigdon, M H Norman, B R Cooper, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Neurotoxicology and Teratology
|
March 1, 1989
Effect of perinatal monosodium glutamate administration on visual evoked potentials of juvenile and adult rats
G C Rigdon, W K Boyes, R S Dyer
Journal of Medicinal Chemistry
|
August 5, 1994
Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents
M H Norman, G C Rigdon, F Navas, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents
M H Norman, G C Rigdon, W R Hall, et al.
Journal of Medicinal Chemistry
|
November 22, 1996
Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents
M H Norman, F Navas, J B Thompson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1983
Dissimilar responses of cortical neurons to chronic trazodone or desipramine treatment
S L Peterson, T C Napier, G C Rigdon, et al.
Life Sciences
|
January 1, 1995
Is clozapine selective for the dopamine D4 receptor?
M J Durcan, G C Rigdon, M H Norman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1993
A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86
K J Chang, G C Rigdon, J L Howard, et al.
Electroencephalography and Clinical Neurophysiology
|
May 1, 1986
Generation of cortical event-related slow potentials in the rat involves nucleus basalis cholinergic innervation
J H Pirch, M J Corbus, G C Rigdon, et al.
Molecular Pharmacology
|
December 20, 2007
N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator
A D Wickenden, J L Krajewski, B London, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 1, 1996
1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects
G C Rigdon, M H Norman, B R Cooper, et al.
Page
of 2